lifeSciences News & Analysis
3 articles
Market Mood
IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B
Ari Bousbib, Chairman and CEO of IQVIA Holdings Inc. (NYSE:IQV), sold about 106,000 shares for proceeds of $26.1 million, according to an SEC Form 4 filing. The shares were sold at a weighted average price of $245.51, slightly below the market close of $247.56 on July 29, 2026. This transaction reduced Bousbib's direct holdings by 11%, but he retains beneficial ownership of 1.4 million shares, including 543,000 shares through the Orohena Trust. This insider sale comes as IQVIA reported record bookings of $3.15 billion, highlighting its robust position in the life sciences industry.
Read More: IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B
IQVIA (IQV) Launches AI Platform to Improve Life Sciences Operations
On March 16, IQVIA Holdings Inc. (IQV) announced the launch of the IQVIA.ai platform, developed in collaboration with Nvidia. The platform aims to enhance operational efficiency in life sciences by integrating healthcare-grade AI with Nvidia's technology. At launch, 19 of the top 20 pharmaceutical companies were reported to be incorporating IQVIA's intelligent agents into their operations. Further enhancements and additional agents are scheduled for release in Q4 2026, indicating the company's commitment to expanding its capabilities in the healthcare space.
Read More: IQVIA (IQV) Launches AI Platform to Improve Life Sciences Operations
Blackstone (BX) Closes $6.3bn Largest Life Sciences Fund Ever
Blackstone (BX) raised $6.3bn, marking the largest ever private funding investment round focused on life sciences. This capital will support the firm's BXLS platform, which aims to aid drug and medical technology development. Over the past year, BXLS has provided nearly $2bn in funding to companies, including $700m to MSD for an antibody-drug conjugate and $400m to Teva for inflammatory bowel diseases. The recent funding highlights ongoing investor interest in life sciences amidst challenging economic conditions.
Read More: Blackstone (BX) Closes $6.3bn Largest Life Sciences Fund Ever